BIOMAT Database Logo BIOMAT Database Logo

Antibodies against AIDS proteins. 1990

Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang

UI MeSH Term Description Entries
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015534 Trans-Activators Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins. Nuclear Trans-Acting Factor,Trans-Acting Factors,Trans-Acting Factor,Trans-Activator,Transactivator,Transactivators,Factor, Nuclear Trans-Acting,Factor, Trans-Acting,Factors, Trans-Acting,Nuclear Trans Acting Factor,Trans Acting Factor,Trans Acting Factors,Trans Activator,Trans Activators,Trans-Acting Factor, Nuclear
D015694 Gene Products, rev Trans-acting nuclear proteins whose functional expression are required for retroviral replication. Specifically, the rev gene products are required for processing and translation of the gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (CAR) in env, also known as the rev-responsive element (RRE), is responsive to the rev gene product. Rev is short for regulator of virion. rev Gene Products,rev Protein,Gene Product, rev,rev Gene Product
D016346 Gene Products, vif Retrovirally encoded accessary proteins that play an essential role VIRUS REPLICATION. They are found in the cytoplasm of host cells and associate with a variety of host cell proteins. Vif stands for "virion infectivity factor". Gene Products, sor,sor Gene Products,vif Gene Products,vif Protein,Gene Product, sor,Gene Product, vif,sor Gene Product,vif Gene Product
D054320 vif Gene Products, Human Immunodeficiency Virus Proteins encoded by the VIF GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV vif Gene Product,vif Gene Products, HIV,vif Proteins, Human Immunodeficiency Virus
D054321 rev Gene Products, Human Immunodeficiency Virus Proteins encoded by the REV GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV rev Gene Product,Trans-Activator Protein, HIV,art-trs Gene Protein, HIV,trs-art Gene Protein, HIV,HIV art-trs Gene Protein,HIV trs-art Gene Protein,Transactivator Protein, HIV,HIV Trans-Activator Protein,HIV Transactivator Protein,HIV art trs Gene Protein,HIV trs art Gene Protein,Trans Activator Protein, HIV,art trs Gene Protein, HIV,trs art Gene Protein, HIV
D054334 Viral Regulatory and Accessory Proteins A broad category of viral proteins that play indirect roles in the biological processes and activities of viruses. Included here are proteins that either regulate the expression of viral genes or are involved in modifying host cell functions. Many of the proteins in this category serve multiple functions. Viral Accessory Proteins,Viral Regulatory Proteins,Regulatory Proteins, Viral,Accessory Proteins, Viral,Proteins, Viral Accessory,Proteins, Viral Regulatory

Related Publications

Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang
Protective Antibodies Against Influenza Proteins.
January 2019, Frontiers in immunology,
Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang
Antibodies against mumps virus component proteins.
August 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang
Antibodies against methionine sulfoxide of proteins.
March 2013, Free radical biology & medicine,
Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang
Generation of antibodies against membrane proteins.
November 2014, Biochimica et biophysica acta,
Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang
Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma.
February 1997, Journal of molecular medicine (Berlin, Germany),
Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang
[ANTIBODIES AGAINST BOVINE PROTEINS IN HUMAN SERUM].
September 1963, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang
Absence of antibodies against prostaglandins in sera of AIDS patients.
January 1986, AIDS research,
Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang
Antibodies against spermatozoids. Studies in homosexuals, AIDS and infertile men.
January 1987, Allergologia et immunopathologia,
Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang
[Antibodies against AIDS-associated virus detected in a Swedish woman].
October 1984, Lakartidningen,
Y Devash, and K Reagan, and D Wood, and J Turner, and M Parrington, and C Y Kang
Cellular response. Are antibodies the most effective defense against AIDS?
December 1992, Scientific American,
Copied contents to your clipboard!